Sit Investment Associates’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.05M | Buy |
64,950
+26,150
| +67% | +$824K | 0.04% | 302 |
|
2025
Q1 | $1.27M | Hold |
38,800
| – | – | 0.03% | 349 |
|
2024
Q4 | $1.4M | Hold |
38,800
| – | – | 0.03% | 349 |
|
2024
Q3 | $1.21M | Hold |
38,800
| – | – | 0.03% | 365 |
|
2024
Q2 | $1.04M | Hold |
38,800
| – | – | 0.02% | 361 |
|
2024
Q1 | $1.32M | Buy |
38,800
+29,350
| +311% | +$1M | 0.03% | 339 |
|
2023
Q4 | $273K | Buy |
+9,450
| New | +$273K | 0.01% | 448 |
|
2019
Q3 | – | Sell |
-19,750
| Closed | -$654K | – | 542 |
|
2019
Q2 | $654K | Hold |
19,750
| – | – | 0.02% | 378 |
|
2019
Q1 | $692K | Hold |
19,750
| – | – | 0.02% | 371 |
|
2018
Q4 | $656K | Hold |
19,750
| – | – | 0.02% | 368 |
|
2018
Q3 | $994K | Buy |
19,750
+2,550
| +15% | +$128K | 0.03% | 334 |
|
2018
Q2 | $1.03M | Hold |
17,200
| – | – | 0.03% | 354 |
|
2018
Q1 | $788K | Buy |
+17,200
| New | +$788K | 0.02% | 375 |
|